Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
ATXI Price/Volume Stats
Current price | $0.21 | 52-week high | $3.93 |
Prev. close | $0.28 | 52-week low | $0.17 |
Day low | $0.20 | Volume | 2,300 |
Day high | $0.24 | Avg. volume | 237,459 |
50-day MA | $0.24 | Dividend yield | N/A |
200-day MA | $1.41 | Market Cap | 662.70K |
ATXI Stock Price Chart Interactive Chart >
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
ATXI Price Returns
1-mo | -16.00% |
3-mo | -73.42% |
6-mo | -87.93% |
1-year | -94.34% |
3-year | -99.93% |
5-year | -100.00% |
YTD | -89.50% |
2024 | -83.44% |
2023 | -86.12% |
2022 | -91.48% |
2021 | -84.74% |
2020 | -38.02% |
Loading social stream, please wait...